Build for Health with Srdjan Injac

You can do everything right in the gym and still undo it on the couch at midnight. Lifting doesn't build muscle while you're lifting. It damages muscle and sends a signal. The rebuilding comes later, mostly while you're asleep, and it depends on conditions that a short night takes away.This episode goes inside that night shift. Deep sleep brings a major pulse of growth hormone, but calling it "the muscle-building hormone" sells short what it's actually doing. Testosterone and the nervous system have their own overnight jobs, and strength turns out to be partly something your brain has to practice in its sleep.Then the harder question: what does a pattern of short nights cost someone who's training and dieting at the same time? One number from the research works out to roughly an extra meal a day, eaten without deciding to. From there it's on to whether the weekend catch-up most of us rely on actually balances the books, what a sleep tracker is good for when it's obviously wrong about last night, and a practical list for people who've slept badly for years.This episode is general information, not medical advice. If you have a diagnosed sleep disorder, work with a specialist.Links & NotesThe Effects of Partial Sleep Deprivation on Energy Balance (Al Khatib et al., European Journal of Clinical Nutrition, 2017). The meta-analysis behind the 385-calorie number: short sleep raised daily intake with no change in calories burned.The Effect of Acute Sleep Deprivation on Skeletal Muscle Protein Synthesis and the Hormonal Environment(Lamon et al., Physiological Reports, 2021). One night without sleep lowered muscle protein synthesis by 18%.Sleep Curtailment in Healthy Young Men Is Associated with Decreased Leptin Levels, Elevated Ghrelin Levels, and Increased Hunger and Appetite(Spiegel et al., Annals of Internal Medicine, 2004). The two hunger hormones from this episode.Ad Libitum Weekend Recovery Sleep Fails to Prevent Metabolic Dysregulation (Depner et al., Current Biology, 2019). The study on weekend catch-up sleep.Episode 40: Rest Is Not One Thing. The four kinds of recovery, plus more sleep research.Episode 5: Recovery Is Not a Reward. Where this conversation started.Work with Srdjan and the team at ELEV8 Fitness in Portland, Oregon.Submit your questions to the show!

Training is the stimulus. It is not the adaptation. That happens later — in the hours we treat as leftover time, and describe with words that all mean absence: rest day, off day, recovery day.This week Pete brings Srdjan a piece of research that has nothing to do with the gym and everything to do with it. In 2007, Sabine Sonnentag and Charlotte Fritz published the Recovery Experience Questionnaire, built on a puzzle they kept running into: hours off didn’t predict who came back restored. Two people take the same weekend. One returns ready. One returns wrecked. Their answer was that recovery isn’t one thing — it’s four, and they don’t substitute for each other. Psychological detachment. Relaxation. Mastery. Control. If you spend all day being told what to do, lying on the couch won’t fix it; you need a rest that hands you back the controls.Srdjan takes that framework into the gym and it holds up uncomfortably well. He walks through what’s actually happening in your body after a hard session — glycogen, protein synthesis, the twenty-four to forty-eight hour repair window — and makes the case that soreness is a lousy measurement of recovery, because different systems come back online at different speeds. Muscles, energy stores, connective tissue, nervous system. None of them are on the same clock.Recovery isn’t separate from training. It is the training. Let’s build.Links & NotesThe Recovery Experience Questionnaire (Sonnentag & Fritz, 2007) — the four-factor model of detachment, relaxation, mastery, and control. Free full text, and the paper that kicked off this whole episode. Also on PubMed.Insufficient Sleep Undermines Dietary Efforts to Reduce Adiposity (Nedeltcheva et al., Annals of Internal Medicine, 2010) — the metabolic ward study, 8.5 versus 5.5 hours of sleep opportunity.Effect of 1 Week of Sleep Restriction on Testosterone Levels in Young Healthy Men (Leproult & Van Cauter, JAMA, 2011).The Effects of Sleep Extension on the Athletic Performance of Collegiate Basketball Players (Mah et al., Sleep, 2011) — every player improved on every measure.Gaining More From Doing Less? (PeerJ, 2024) — the thirty-nine-lifter deload study. Free full text.Work with Srdjan and the team at ELEV8 Fitness in Portland, Oregon.Submit your questions to the show!

A calorie deficit takes energy away. Building muscle demands it. Whether you can do both at once depends almost entirely on where you're starting from, and the answer for a beginner is not the answer for someone ten years in.Exercise order comes next. The case for doing compound lifts first has nothing to do with those lifts being better. It's about energy: what a squat asks of you versus what a leg extension asks, and what happens to your form once the tank is empty. There are limits to that rule, and they're worth knowing before you treat it as gospel.Then the timeline questions. One listener has a baby on the way and a month with no gym in front of him, and wants to know when "you don't lose it that fast" stops being true. Another is 67. His doctor just told him muscle is the organ of longevity and to start lifting. His adult kids are terrified.Then the peptide mail. What an FDA advisory vote actually does, and what it doesn't. Why a yes vote is not an approval. Who pays for trials on a molecule nobody can patent, and what happens if the answer is nobody. Plus a listener six weeks into treating his own elbow, asking when "we need more human trials" stops being caution and starts being a gate.Corrections & ContextWe check the big factual claims after every episode. Here's what needs fixing, what needs more context, and what held up. Everything links to a source so you can check us.What we got wrong1. You can't currently get these peptides from a compounding pharmacy. On air we described the FDA committee's vote as clearing the way for a doctor to write a prescription and a compounding pharmacy to fill it. That isn't where things stand. The Pharmacy Compounding Advisory Committee met July 23–24, 2026 and voted, but an advisory committee vote is not an agency action. Nothing has legally changed. Before any of these substances can be compounded, the FDA has to accept the recommendation and add it to the 503A Bulks List through formal notice-and-comment rulemaking, and that process hasn't started. As of this writing, none of the seven peptides reviewed in July can legally be compounded. → FDA's Advisory Committee Votes on Peptides: What It Does and Doesn't Do — Mintz (July 29, 2026) → What the Peptide Vote Actually Changes at My Counter (Hint: Not Much, Yet) — Pharmacy TimesOne thing to separate out: plenty of peptides remain legally compoundable and always have. The seven under review are the exception.2. The FDA did not lose in court. We said the agency "lost in court" and that's why the peptides came back. No such loss happened. The path back ran through the executive branch: the FDA removed twelve peptides from Category 2 in April 2026 after their nominations were withdrawn, then sent them to the advisory committee. Where compounding has actually been fought in court lately — the Outsourcing Facilities Association suits over GLP-1 shortage delisting — the FDA won. Judges denied the compounders' injunctions in both the semaglutide and the tirzepatide cases. → FDA clarifies policies for compounders — U.S. Food and Drug Administration → Court Backs FDA in Tirzepatide Compounding Case — McDermott3. "Peptides are not drugs" is backwards. "Peptide" describes a chemical: a short chain of amino acids. "Drug" describes a legal category. Something can be both, and most peptide medicines are. Ozempic and Wegovy are FDA-approved drugs whose active ingredient is a peptide. BPC-157 is also a drug under federal law, just an unapproved one, which is why selling it for human use is illegal. Your body making peptides doesn't change that, any more than your body making cortisol makes prednisone a supplement. This is our own basil-and-nightshade point from the peptides episode, and we dropped it. → Wegovy (semaglutide) prescribing information — FDA → Understanding the Legal Risks of BPC-157 and Other Unapproved Peptides — Holt Law4. "There are no human trials, and there never will be any" is too strong on both halves. Human studies exist. They're small, old, and mostly unpublished in full. Under the development name PL-14736, BPC-157 went through a safety and pharmacokinetics study in healthy volunteers (Gut, 2003) and a randomized, double-blind, placebo-controlled Phase II study in ulcerative colitis (Gastroenterology, 2005). A Phase I safety trial in 42 volunteers was registered in 2015 (NCT02637284) and cancelled without published results. The most recent human data is a 2025 intravenous safety pilot in two people. Fewer than thirty published human subjects, total. That's a bad number, but it isn't zero, and "no trials" and "almost no data" lead to different conversations.The "never will be" half is fair as far as it goes. A molecule without strong patent protection has little commercial money behind it. But academic and government-funded trials happen all the time. And there's an irony from the committee itself: some members argued that allowing compounding would open the door to more study, while the counterargument is that selling it commercially removes any reason to ever run the trial. → Is BPC-157 safe for use in humans? — InpharmD evidence summary, with primary citations → Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study — PubMed5. The vote was six of seven, not two — and our earlier reporting needs updating too. We've been describing the July meeting as a narrow win for BPC-157 and KPV with the others still pending. The final tally: the committee recommended adding BPC-157, KPV, TB-500, MOTS-c, epitalon, and semax to the 503A list, and voted againstemideltide (DSIP). Two things matter more than the count. The FDA's own scientific reviewers recommended against all seven. And each peptide was judged against one specific medical use — BPC-157 was assessed for ulcerative colitis, not tendons or elbows or recovery. The uses driving all the demand were never on the ballot. → FDA Expert Panel Backs Compounding of Six Peptides — Medscape → FDA briefing documents and meeting materials, July 23–24, 2026 PCAC6. There is no 300-pound threshold for GLP-1 medications. We talked about eligibility in pounds. The FDA label uses BMI: 30 or greater, or 27 or greater with at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia. Someone hoping to lose twenty-five pounds may well qualify. Someone who weighs three hundred p...

A peptide is a short chain of amino acids. That's the entire definition. Insulin is a peptide. So is the drug in Ozempic. So are BPC-157 and TB-500 — compounds athletes have used for injury recovery for years, and which the FDA moved to a restricted list in September 2023, citing limited human safety data.In late July, an FDA advisory committee spent two days voting on whether pharmacies should be allowed to make seven of them again. Six passed. Every vote was close. The agency's own scientists had recommended against all seven.This episode covers what a peptide actually is, and why the word alone tells you nothing about whether something is safe. Why compounding pharmacies sit at the center of a fight involving big pharma, a federal agency, and a health secretary who has called himself a fan. What the research on BPC-157 actually consists of — and why "over a hundred studies" is a more complicated number than it sounds. And the distinction that most of the coverage got wrong: legal to compound is not the same as FDA-approved, and nothing changed at the pharmacy counter the day after that vote.Also in here: what happens to a supply chain when the legal version disappears, the gas-station-sushi test for anything you're considering injecting, and why one strength coach is booking a conversation with his physician about his own shoulder.Nothing in this episode is medical advice. The recommendation, start to finish, is the same one: talk to your doctor.The news, as of this episodeFDA advisory panel narrowly backs six of seven peptides — Associated Press via PBS NewsHour: https://www.pbs.org/newshour/health/watch-live-day-2-of-fda-advisory-panel-meeting-to-consider-use-of-peptidesPanel backs epitalon and semax, rejects emideltide — STAT, July 24, 2026: https://www.statnews.com/2026/07/24/fda-peptide-compounding-panel-backs-epitalon-rejects-emideltide/FDA staff and peptide advocates clash at advisory panel — STAT, July 23, 2026: https://www.statnews.com/2026/07/23/fda-advisory-panel-peptide-safety-compounding-pharmacies/What the peptides are and what happens next — CNN, July 31, 2026: https://edition.cnn.com/2026/07/31/health/what-are-peptides-fda-next-steps-wellnessFDA panel supports broadening access — NPR, July 23, 2026: https://www.npr.org/2026/07/23/nx-s1-5903202/fda-peptides-restrictionsVote-by-vote breakdown — American Journal of Managed Care: https://www.ajmc.com/view/fda-panel-backs-6-peptides-for-compoundingCommittee backs two more, rejects one — Regulatory Affairs Professionals Society: https://www.raps.org/resource/fda-advisory-committee-backs-two-more-peptides-rejects-one-for-compounding-list.htmlWhat the vote does and doesn't doA pharmacist on what the reclassification actually means — Pharmacy Times: https://www.pharmacytimes.com/view/the-peptide-reclassification-everyone-s-talking-about-a-pharmacist-s-take-on-what-rfk-jr-s-announcement-actually-meansLegal analysis of the committee's votes — Mintz: https://www.mintz.com/insights-center/viewpoints/2146/2026-07-29-fdas-advisory-committee-votes-peptides-what-it-does-andFDA's removal of twelve peptides from Category 2, and what it doesn't mean — Orrick: https://www.orrick.com/en/Insights/2026/04/FDA-Announces-Removal-of-12-Peptides-from-Category-2-and-Schedules-PCAC-MeetingsOn the conflict-of-interest questionFDA advisers back looser rules for six peptides — Bloomberg Law: https://news.bloomberglaw.com/health-law-and-business/fda-review-committee-rejects-first-peptide-in-second-day-hearingPrimary sourceFDA: July 23–24, 2026 Meeting of the Pharmacy Compounding Advisory Committee: https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026The showELEV8 Fitness: https://elev8fitnesspdx.comSubmit your questions!

At a routine physical, a doctor charts blood pressure, weight, cholesterol, and triglycerides — a page of numbers meant to forecast the years ahead. None of them measure how strong you are. That's a strange omission, because muscle strength is one of the most reliable predictors of both lifespan and healthspan that researchers have found — in some studies, a better predictor than the blood-pressure reading sitting right next to it on the chart. This episode of Build for Health, with host Pete Wright and ELEV8 strength coach Srdjan Injac, examines the gap between what the exam room measures and what actually keeps a body running — and why that gap exists in the first place.The trail starts in medical training itself. Across four years of U.S. medical school, students receive on average roughly nineteen hours of nutrition education — under one percent of total instruction — and most of that is biochemistry, not how to counsel a patient on what to eat for breakfast. The result isn't ignorant doctors; it's a system built to diagnose and treat disease rather than prevent it, and one that gives a clinician about eight minutes per visit to do it. From there the episode turns to what the research actually rewards: grip strength, leg strength, walking speed, and total muscle mass — each of which tracks with how long and how independently people live. Low muscle mass even has a clinical name, sarcopenia, and a real cost, from falls and fractures to the loss of being able to stand up unassisted. The throughline is that strength isn't cosmetic. It's infrastructure.Underneath the specifics is a harder question about who owns prevention. When a visit is built around treating the number — a statin for cholesterol, a pill for blood pressure, another for blood sugar — the lifestyle changes that move the underlying condition can go unmentioned. Type 2 diabetes is the sharpest example: in clinical trials, substantial weight loss has put nearly half of shorter-duration cases into remission. The takeaway isn't that medicine is the enemy, and it certainly isn't that anyone should stop a prescription on their own. It's that absence of advice is not absence of importance — and that the strongest move a patient can make is to walk into the exam room asking not just how to fix a number, but how to keep it from coming back.KEY TAKEAWAYSStrength is an unmeasured vital sign. A standard physical records a dozen numbers that predict your health — but not how strong you are, even though strength rivals or beats several of them as a predictor.Grip strength is a whole-body signal. It correlates with all-cause mortality, cardiovascular disease, and future disability — in large prospective research, more strongly than systolic blood pressure. (The point isn't to train your hands; grip is a proxy for total-body strength and resilience.)Walking speed predicts survival. Especially after age 65, usual walking pace integrates strength, balance, cardiovascular fitness, and nervous-system function into one accessible measure of vitality.Leg strength buys independence. The legs hold the largest muscles in the body; maintaining them lowers the risk of falls, fractures, and the loss of everyday autonomy — including the ability to get up off the floor, or off the toilet, without help.Low muscle mass has a name and a cost. Sarcopenia — age-related loss of muscle — is linked to higher disease and disability risk. You can carry less mass and still be strong, which is why strength, not size, is the goal.Med school barely covers nutrition. U.S. medical students average ~19 hours of nutrition across four years, under 1% of instruction — and most of it is biochemistry, not practical dietary counseling. The gap is structural, not personal.Lifestyle can move the underlying condition, not just the number. Resistance training, better nutrition, and weight loss can improve blood pressure, cholesterol, and blood sugar at the source. Type 2 diabetes remission is well-documented in shorter-duration cases following significant weight loss.Ask prevention questions, not just prescription questions. "How do I keep this from coming back?" is a different conversation than "What do I take for this?"Safety note: Nothing here is medical advice, and no one should start, stop, or change a medication on their own. Decisions about prescriptions — including any wind-down — belong with your own clinician.GLOSSARYSarcopenia — Age-related loss of skeletal muscle mass and strength; associated with higher risk of falls, disability, and disease.Grip strength — Force generated by the hand, typically measured with a hand dynamometer. Used as a low-cost proxy for total-body strength and a research-validated predictor of mortality and disease risk.Gait speed (walking speed) — Usual walking pace, measured over a short distance. A simple, strong indicator of healthy aging and survival because it draws on multiple body systems at once.Sarcopenia vs. weakness — You can have less muscle mass but still be strong; the episode stresses that strength and function matter more than size alone.Type 2 diabetes remission — Return of blood sugar to a non-diabetic range without medication, sustained through lifestyle change. Remission is documented (especially in shorter-duration disease) but is not the same as a permanent cure; it depends on maintaining the habits.Statin — A class of drugs that lowers cholesterol; cited as an example of treating the number rather than the cause.Insulin resistance — Reduced response of cells to insulin, a key driver of type 2 diabetes; improved by activity, muscle, and fat loss.Naturopath / naturopathic medicine — A practitioner approach that, as described in the episode, emphasized longer visits, lifestyle, and prevention. (Scope of practice and licensing vary by state.)LINKS & NOTESSawbones: A Marital Tour of Misguided Medicine — Dr. Sydnee McElroy and Justin McElroy's medical-history podcast (Maximum Fun): https://maximumfun.org/podcasts/sawbones/ELEV8 Fitness: https://elev8fitnesspdx.comThe evidence behind this episodeNutrition in med school: "The State of Nutrition Education at US Medical Schools," Journal of Biomedical Education, 2015 — https://onlinelibrary.wiley.com/doi/10.1155/2015/357627Grip strength vs. blood pressure as a mortality predictor: Leong et al., PURE study, The Lancet, 2015 — https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)62000-6/abstractWalking speed and survival: Studenski et al., "Gait Speed and Survival in Older Adults," JAMA, 2011 — https://doi.org/10.1001/jama.2010.1923Type 2 diabetes remission via weight loss: Lean et al., DiRECT trial, The Lancet, 2018 — https://pubmed.ncbi.nlm.nih.gov/29221645/

Spend ten minutes on the wellness internet and you'll learn that women's health runs on one vengeful hormone, that carbs are a betrayal, and that the fix is a protocol synced to your cycle. The kernel of truth — most fitness research was done on men — keeps getting buried under products, calendars, and miracle drugs. This episode digs for the science underneath.What actually changes when you train a woman instead of a man? Less than you'd think. From there: the real cost of GLP-1 drugs, what fasting and keto quietly do to hormones and energy, whether cycle-syncing is science or a $40 grift, and why cortisol isn't the villain your feed makes it out to be.The throughline is the least marketable advice in fitness: balance beats extremes, and the scale is the wrong thing to track. Every shortcut here sells speed at the expense of the one thing that compounds over a lifetime — the muscle and bone you build the slow way.Key TakeawaysProgramming for women and men is more alike than different. Same core exercises; the real variables are intensity and recovery, adjusted to where someone is in their cycle and how they feel day to day."Bulky" is largely a myth. Building significant size is genuinely hard and isn't a default risk of lifting heavy.GLP-1 medications carry an off-label cost. Roughly a quarter of the weight lost can be muscle, and falling estrogen accelerates bone loss — a setup for osteopenia and, later, osteoporosis.The drugs are legitimately useful for real medical need, but become a problem when used as a permanent shortcut with no nutrition education and no training to protect muscle.Fasting and keto trade fast scale drops for thyroid suppression, disrupted estrogen, irregular or missing periods, and lower energy — and the effects hit lean, active women hardest.Carbs aren't the enemy. A floor of about 150g per day supports estrogen and thyroid function; too little for too long reads to the body as a famine signal.Cycle phases are real, but cycle-syncing products oversell them. Strength tends to peak in the follicular-to-ovulatory window; the luteal phase brings fatigue, cravings, bloating, and water retention. The answer is personalization and adapting effort — not quitting the gym.Cortisol is essential, not evil. It regulates energy, blood sugar, and the sleep-wake cycle. Chronic elevation is the issue, and even then it works through behavior (cravings, poor sleep, low recovery) rather than directly causing fat gain.The scale lies daily. Two-to-five-pound swings in 24 hours are normal and almost never fat. Track body composition and performance instead.The shortcut is the trap. Medications, extreme diets, and trend protocols sell speed; muscle and bone are built slowly and pay off for the rest of your life.Liked what you heard? Srdjan, Brooke, and Kaila are all coaches at ELEV8 Fitness — and you can train with them in real life, not just in your earbuds. No shortcuts, no $40 cycle calendars. Just real programming built for your body and your life. Start at elev8fitnesspdx.com.

t starts with one of the most common questions Srdjan gets at the gym: "What should I weigh?" A client asked it that very morning — wanting one number, for her height, that would mean she was healthy. But that number doesn't exist, and chasing it might be the thing holding people back. Healthy weight isn't a point on a scale; it's a range where your body functions, recovers, and performs well.From there, Pete and Srdjan take apart the whole toolkit we've been handed. The bathroom scale tells you nothing about muscle, metabolism, or health — two people at the same weight can be worlds apart inside, which is how "skinny fat" happens. BMI is worse: Pete traces its strange pedigree from a Belgian astronomer named Adolphe Quetelet, who built it in the 1830s to describe the statistical "average man" and explicitly warned against using it on individuals, to physiologist Ancel Keys, who rebranded it as the Body Mass Index in 1972 after studying white European and American men. It stuck because insurance companies wanted to predict how likely you are to die. The conversation moves into what Srdjan does measure instead — muscle mass — and why the body fat percentages you see on social media are a temporary, miserable, peak-week illusion that even competitors can't hold onto year-round.A genuinely healthy, strong person looks kind of normal. You'll know it by how you feel — energy, strength, good labs, the ability to get out of a chair unassisted at 80 — not by whether your abs show in July. And because a body that's causing you stress and anxiety isn't actually healthy, the real goal is feeling good physically and mentally, without the extremes. Build muscle, stop measuring the wrong things, and throw the scale away.KEY TAKEAWAYSHealthy weight is a range, not a number. It's where your body functions well — balanced muscle and body fat, stable energy, good recovery, healthy labs.The scale measures the least useful thing. It can't see muscle, metabolism, or visceral fat. "Skinny fat" — thin on the outside, metabolically unhealthy on the inside — is the proof.BMI has a questionable pedigree. Built by an astronomer for population statistics, never meant for individuals, popularized by insurers tracking mortality. It can't tell muscle from fat, which is why Srdjan himself gets classified as "obese."Muscle mass is the number to watch. More muscle speeds metabolism, lowers body fat (including visceral fat), and regulates nearly everything. And it declines with age, so building it early matters.Focus on what you're gaining, not losing. Reframing from "I need to lose weight" to "I need to build muscle" is what actually produces fat loss — and it sticks.Single-digit body fat is a peak-week illusion. Those shredded photos are taken right after a competition; even competitors can't maintain it. Around 20% body fat can be perfectly healthy with good muscle mass.Health is psychological too. If a target weight or body fat is causing stress and anxiety, that's a sign it's the wrong target.The stuff that matters doesn't photograph. Joint health, mobility, getting out of a chair at 80 — none of it shows up in a Speedo shot, and all of it matters more.Links & NotesSubmit your questions to the show!

You can hit the gym four times a week and still be quietly undone by your chair. That's the uncomfortable thesis behind what's been called "the sitting disease," and in this episode, Pete Wright sits down (ironically) with strength coach Srdjan Injac to walk through exactly what eight to ten hours of daily sitting does to the human body.The conversation moves region by region. The thoracic spine stiffens. The diaphragm gets compressed and breathing goes shallow. The hip flexors tighten until the glutes — which are supposed to be one of the strongest muscles in your body — essentially clock out. Lower back pain gets blamed on the back, when the real problem is everything around it. And then Srdjan goes inside, where the sitting disease gets genuinely uncomfortable: glucose handling declines, insulin sensitivity drops, and within sixty to ninety minutes of sitting, an enzyme called lipoprotein lipase — the gatekeeper that pulls fats out of your bloodstream — falls off a cliff.The payoff is practical. Stand up every hour. Take walking meetings. Get the steps in, not because anyone needs to see them but because your metabolism needs the movement. And when you do get to the gym, expect the work to be uncomfortable in the right way — split squats that finally stretch what's been flexed all day, exercises that activate muscles you forgot you had. The mindset shift here is the whole episode in one sentence: hurt is not broken. Hurt is on the mend. Movement isn't a workout you complete and check off. It's a feature of your day.If you've ever wondered why you're doing everything right and still feeling stiff, sluggish, and slowly heavier — this episode is the answer, and the way out.Links & NotesSubmit your questions to the show!

Here's something that should be obvious but apparently isn't: ADHD and the gym should be a natural fit. The gym produces dopamine. ADHD is a dopamine regulation disorder. That math seems like it should close cleanly. And yet if you have ADHD — or suspect you might — the gym is probably also the place where you've set personal records for giving up. You signed up with great intentions. You went for two weeks. You lost the routine, felt terrible about it, and quietly concluded you're just not a gym person. The problem is that's wrong, and the fitness industry is largely to blame.Here's the thing: Pete Wright co-wrote Unapologetically ADHD. He has spent years deep in the research on how ADHD brains actually work. He knows the neuroscience, the behavioral patterns, the strategies that help and the ones that don't. And he still could not make himself go to the gym consistently for most of his adult life — until Srdjan. This episode is Pete and Srdjan reverse-engineering why that changed: why standard gym advice is essentially designed to fail neurodiverse brains, why Srdjan's approach at ELEV8 is accidentally one of the most ADHD-compatible training environments around, and what a fitness practice looks like when it's built for how your brain actually works rather than how everyone assumes it does. There's real science here (exercise produces the same neurological effect as a low-dose stimulant, which is a sentence that deserves a minute to sit with), and there are practical tools for anyone who has been told their entire lives t

You had questions after our Programming 101 episode, and Pete and Srdjan are back to answer them. This week it's Programming 102 — a listener-driven deep dive into the mechanics of building a training program that actually adapts as you do. If you've ever missed a week and panicked, wondered whether you can train your upper and lower body on totally different systems, or felt vaguely like you should be doing something "more advanced" by now without knowing what that actually means, this episode is for you.Srdjan clears up one of the most common sources of unnecessary anxiety in strength training: missing a week. Spoiler — one week off is not the catastrophe your brain says it is. Unless you were seriously ill or running on fumes, you probably just gave your body some extra recovery time. He also breaks down concurrent periodization — the practice of training different physical qualities at the same time, like strength for your lower body while chasing hypertrophy up top. It's not just something advanced athletes do. Srdjan does it himself, and the logic is straightforward once you understand it.Then there's the big one: how do you know when you're ready to graduate from beginner linear programming? The honest answer is you'll feel it before you fully understand it — when the weight stops going up every session, when you stop getting sore, when the workouts feel too predictable. Srdjan walks through what that transition looks like and introduces the concept of "shocking the muscle" — which, as Pete discovers, has a lot less to do with adding weight and a lot more to do with changing angles, order, tempo, tools, and expectation. Gravity eventually wins if all you do is chase heavier.Whether you're three months in or three years in, this episode is a useful gut-check on where you are in your training arc and what it means to keep making progress without just piling on plates.Links & NotesSubmit your questions to the show!

Here's the uncomfortable truth about most people's fitness routine: it's not a routine. It's a vibe. A loosely organized collection of exercises they kind of remember, performed at an intensity that feels appropriately unpleasant, repeated until boredom or injury ends the whole experiment. That's not training. That's just being tired on purpose.This week, Pete and Srdjan get into what separates people who actually progress from people who have been "getting back into it" for the last four years. The answer is periodization — which sounds like the kind of word a personal trainer uses to justify charging more, but is actually just the radical idea that your workouts should have a plan. A real one. With phases. And a reason.Srdjan walks through the three main approaches — linear periodization for beginners building their foundation, non-linear for intermediate lifters juggling real life, and block periodization for more advanced athletes chasing specific adaptations. He also explains the deload — the week where you go lighter on purpose, which feels like cheating but is actually the thing that lets you keep going.They also get into the mechanics of how a real program is built: why you start with higher reps and lower weight before you ever touch anything heavy, what progressive overload actually looks like in practice, and — crucially — why loading your biceps the same way you'd load your back is how people end up hurt and confused.Pete has questions. Reasonable ones. Like: does more sweat mean a better workout (no), do you have to change exercises constantly to keep making progress (also no), and does every set need to go to failure (please, no). Srdjan dismantles all of them with the patient authority of someone who has watched a lot of people make these mistakes in real time.And at the end, Srdjan shares what actually makes him feel like the training is working — and it's not a personal best on an app. It's a stranger at a grocery store. Which turns out to be the most unexpectedly useful piece of advice in the whole episode.Links & NotesSubmit your questions to the show!Looking for a Trainer? Reach Out!

This one is about the part of training nobody romanticizes: coming back after injury or surgery without letting impatience take the wheel. We start with a real-world case—Pete’s business partner Andy facing back-to-back knee replacements—and uses that as a proxy for anyone staring down rehab, physical therapy, and the uneasy question of “When am I actually ready to train again?” Srdjan lays out what he wants to know first (medical notes, PT progress, movement limits), and why the handoff from PT to strength work matters: PT gets you functional, but strength training is where you rebuild the stability and muscle support that keeps you from getting hurt again.A big thread here is pain literacy. Srdjan talks about learning to distinguish discomfort from danger—aching versus sharp pain, soreness versus joint pain—and how a good coach watches movement as much as they listen to words (because most of us underreport what we’re feeling). They also unpack the two classic traps: the underconfident “I can’t train until I’m pain-free” and the overconfident “It doesn’t hurt, so I’m fine,” and why both can get you into trouble. The throughline is slowing down, staying in control, and treating old injuries with ongoing respect even years later.They also get practical: using the pool to reduce joint load while keeping muscles active, prioritizing stabilizers and unilateral work for asymmetries, and reframing “rest” as active recovery rather than full stop. And there’s a nice, slightly sneaky lesson for the rehab window: if your training options shrink, tighten up what you can control—protein, calories, and habits—so the setback is real but not catastrophic.Links & NotesSubmit your questions to the show!